CARF (CDKN2AIP) Regulates Hepatic Lipid Metabolism and Protects Against Development of Non-Alcoholic Fatty Liver Diseases

Non-alcoholic fatty liver diseases (NAFLD) is the most common form of liver diseases in the USA with 30–40% of American being affected and about 12% with nonalcoholic steatohepatitis (NASH), a leading cause of end-stage liver diseases. NAFLD has been linked with insulin resistance, type2 diabetes, o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Hasan, Kamrul M, Parveen, Meher, Pena, Alondra, Calles, Erick Galdamez, Gergis, Marvy, Espinoza-Derout, Jorge, Sinha-Hikim, Amiya, Friedman, Theodore C
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Cardiovascular Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089945/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.577
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky